Monica Giovannini

2.0k total citations
35 papers, 744 citations indexed

About

Monica Giovannini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Monica Giovannini has authored 35 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Monica Giovannini's work include Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Research Studies (9 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Monica Giovannini is often cited by papers focused on Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Research Studies (9 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Monica Giovannini collaborates with scholars based in Italy, United States and Switzerland. Monica Giovannini's co-authors include Francesca Spada, Nicola Fazio, Chiara Catania, Carmen Belli, Lorenzo Spaggiari, Francesca Toffalorio, Massimo Barberis, Michela Manzotti, Angelo Delmonte and Filippo de Braud and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and European Journal of Cancer.

In The Last Decade

Monica Giovannini

35 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Monica Giovannini Italy	14	473	414	204	151	128	35	744
Raymond Wadlow United States	14	485 1.0×	179 0.4×	484 2.4×	196 1.3×	138 1.1×	36	944
Ho-Yeong Lim South Korea	17	345 0.7×	308 0.7×	301 1.5×	140 0.9×	120 0.9×	31	863
Monika Serke Germany	15	688 1.5×	758 1.8×	194 1.0×	104 0.7×	129 1.0×	71	1.1k
Zhi-Qin Jiang United States	11	564 1.2×	274 0.7×	336 1.6×	205 1.4×	46 0.4×	12	881
Cheng‐Bo Han China	17	381 0.8×	471 1.1×	270 1.3×	190 1.3×	41 0.3×	76	864
Caio Max S. Rocha Lima United States	14	537 1.1×	253 0.6×	204 1.0×	114 0.8×	156 1.2×	39	735
Mitchell D. Nambu United States	3	286 0.6×	271 0.7×	351 1.7×	76 0.5×	33 0.3×	3	648
Eileen Regan United States	16	620 1.3×	238 0.6×	200 1.0×	94 0.6×	361 2.8×	34	907
Yun-shan Tan China	16	296 0.6×	376 0.9×	190 0.9×	152 1.0×	74 0.6×	52	851
J.M.G.H. van Riel Netherlands	14	720 1.5×	415 1.0×	199 1.0×	382 2.5×	59 0.5×	25	989

Countries citing papers authored by Monica Giovannini

Since Specialization

Citations

This map shows the geographic impact of Monica Giovannini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Giovannini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Giovannini more than expected).

Fields of papers citing papers by Monica Giovannini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Giovannini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Giovannini. The network helps show where Monica Giovannini may publish in the future.

Co-authorship network of co-authors of Monica Giovannini

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Giovannini. A scholar is included among the top collaborators of Monica Giovannini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Giovannini. Monica Giovannini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wolf, Jürgen, Pierre-Jean Souquet, Kōichi Goto, et al.. (2023). Improved Survival Outcomes in Patients With MET-Dysregulated Advanced NSCLC Treated With MET Inhibitors: Results of a Multinational Retrospective Chart Review. Clinical Lung Cancer. 24(7). 641–650.e2. 3 indexed citations

Tan, Daniel S.W., Sang‐We Kim, Santiago Ponce Aix, et al.. (2022). Nazartinib for treatment-naive EGFR-mutant non−small cell lung cancer: Results of a phase 2, single-arm, open-label study. European Journal of Cancer. 172. 276–286. 11 indexed citations

Chen, Xinhui, Xiaoming Cui, Michelle Quinlan, et al.. (2021). Pharmacokinetics of capmatinib in participants with hepatic impairment: A phase 1, open‐label, single‐dose, parallel‐group study. British Journal of Clinical Pharmacology. 88(1). 91–102. 7 indexed citations

Garon, Edward B., Rebecca S. Heist, Takashi Seto, et al.. (2020). Abstract CT082: Capmatinib in METex14-mutated (mut) advanced non-small cell lung cancer (NSCLC): Results from the phase II GEOMETRY mono-1 study, including efficacy in patients (pts) with brain metastases (BM). Cancer Research. 80(16_Supplement). CT082–CT082. 17 indexed citations

Wolf, Juergen, Tobias R. Overbeck, Ji‐Youn Han, et al.. (2020). Capmatinib in patients with high-level MET-amplified advanced non–small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study.. Journal of Clinical Oncology. 38(15_suppl). 9509–9509. 11 indexed citations

Grande, Enrique, Monica Giovannini, Philippe Pultar, et al.. (2020). Effect of capmatinib on the pharmacokinetics of digoxin and rosuvastatin administered as a 2‐drug cocktail in patients with MET‐dysregulated advanced solid tumours: A phase I, multicentre, open‐label, single‐sequence drug–drug interaction study. British Journal of Clinical Pharmacology. 87(7). 2867–2878. 14 indexed citations

Heist, Rebecca S., Takashi Seto, Ji‐Youn Han, et al.. (2019). CMET-22. CAPMATINIB (INC280) IN METΔEX14-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): EFFICACY DATA FROM THE PHASE 2 GEOMETRY MONO-1 STUDY. Neuro-Oncology. 21(Supplement_6). vi56–vi56. 13 indexed citations

Heist, Rebecca S., Edward B. Garon, Daniel S.W. Tan, et al.. (2019). Abstract A029: Biomarker analysis of patients with METΔex14 mutated non-small-cell lung cancer (NSCLC) treated with capmatinib in the GEOMETRY mono-1 study. Molecular Cancer Therapeutics. 18(12_Supplement). A029–A029. 3 indexed citations

Bauer, Todd M., Martin Schüler, Rossana Berardi, et al.. (2016). MINI01.03: Phase (Ph) I Study of the Safety and Efficacy of the cMET Inhibitor Capmatinib (INC280) in Patients with Advanced cMET+ NSCLC. Journal of Thoracic Oncology. 11(11). S257–S258. 11 indexed citations

10.

Pas, Tommaso De, Monica Giovannini, María Rescigno, et al.. (2012). Vaccines in non-small cell lung cancer: Rationale, combination strategies and update on clinical trials. Critical Reviews in Oncology/Hematology. 83(3). 432–443. 24 indexed citations

11.

Fazio, Nicola, Francesca Spada, & Monica Giovannini. (2012). Chemotherapy in gastroenteropancreatic (GEP) neuroendocrine carcinomas (NEC): A critical view. Cancer Treatment Reviews. 39(3). 270–274. 57 indexed citations

12.

Toffalorio, Francesca, Davide Radice, Lorenzo Spaggiari, et al.. (2012). Features and Prognostic Factors of Large Node-Negative Non–Small-Cell Lung Cancers Shifted to Stage II. Journal of Thoracic Oncology. 7(7). 1124–1130. 1 indexed citations

13.

Pas, Tommaso De, Francesca Toffalorio, Michela Manzotti, et al.. (2011). Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor Receptor Mutations. Journal of Thoracic Oncology. 6(11). 1895–1901. 106 indexed citations

14.

Giovannini, Monica, et al.. (2010). Antiangiogenic strategies in breast cancer management. Critical Reviews in Oncology/Hematology. 76(1). 13–35. 18 indexed citations

15.

Belli, Carmen, Dean A. Fennell, Monica Giovannini, Giovanni Gaudino, & Luciano Mutti. (2009). Malignant pleural mesothelioma: current treatments and emerging drugs. Expert Opinion on Emerging Drugs. 14(3). 423–437. 34 indexed citations

16.

Giovannini, Monica, Vanesa Gregorc, Maria Grazia Viganò, et al.. (2007). Endothelial Growth Factor Receptor Inhibition after Radiotherapy. Journal of Thoracic Oncology. 2(7). 662–662. 1 indexed citations

17.

Spreafico, Anna, Vanesa Gregorc, Rafał Dziadziuszko, et al.. (2007). P3-088: Serum E-cadherin does not associate with response to gefitinib in patients with non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology. 2(8). S716–S716. 1 indexed citations

18.

Molino, Annamaria, Monica Giovannini, A. Auriemma, et al.. (2006). Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer. Critical Reviews in Oncology/Hematology. 59(3). 226–233. 49 indexed citations

19.

Giovannini, Monica, et al.. (2006). Mammary Paget's disease occurring after mastectomy. World Journal of Surgical Oncology. 4(1). 51–51. 6 indexed citations

20.

Perrin, J, Joanny Gouvernet, T. Noguchi, et al.. (2001). MSH2 and MLH1 immunodetection and the prognosis of colon cancer. International Journal of Oncology. 19(5). 891–5. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact